While there is no consensus on a gene panel to determine the CIMP status of a tumour, one of the most commonly used is the Weisenberger panel of genes comprising of CACNA1G, NEUROG1, RUNX3, SOCS1 and IGF2 [4]. Here, CACNA1G is linked to neoplasm.